fda warning letters compounded semaglutide telehealth 2024 2025 issued 30 to companies for false and misleading claims about GLP-1 products. This marks the second round of enforcement action since the agency's September crackdown on misleading FDA warnings against compounded GLP-1s
Description
This one tested whether semaglutide could help heart disease patients
In recent trials, it is slightly more effective than semaglutide Liraglutide is the oldest of this family of medications, being available since 2010, with similar benefits, though, generally with less weight loss than the newer agents

However, discontinuation without maintaining lifestyle changes may lead to weight regain
But a 'no' from Aetna is not necessarily the end of the road

Meaningful weight loss is usually noticed after 2-3 months of consistent use

These branded products also contain semaglutide as the active ingredient, but their inactive ingredient profiles may differ slightly
